CONCORDBIO.NS
CONCORDBIO.NS
INE338H01029
CONCORD BIOTECH LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 10.463.581.000 11.798.178.000
11.3%
Cost of Revenue 2.599.855.000 3.177.056.000
18.2%
Gross Profit 7.863.726.000 8.621.122.000
8.8%
4.815.369.000 3.987.653.000
20.8%
Operating Income 3.048.357.000 4.633.469.000
34.2%
Pretax Income 3.446.472.000 4.945.533.000
30.3%
Net Income Common Stockholders 2.609.059.000 3.716.423.000
29.8%
-- --
--
-- --
--
ende